| Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies Z An, O Aksoy, T Zheng, QW Fan, WA Weiss Oncogene 37 (12), 1561-1575, 2018 | 513 | 2018 |
| Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence A Chicas, X Wang, C Zhang, M McCurrach, Z Zhao, O Mert, RA Dickins, ... Cancer cell 17 (4), 376-387, 2010 | 420 | 2010 |
| BRD4 connects enhancer remodeling to senescence immune surveillance N Tasdemir, A Banito, JS Roe, D Alonso-Curbelo, M Camiolo, ... Cancer discovery 6 (6), 612-629, 2016 | 324* | 2016 |
| A kinase inhibitor targeted to mTORC1 drives regression in glioblastoma QW Fan, O Aksoy, RA Wong, S Ilkhanizadeh, CJ Novotny, WC Gustafson, ... Cancer cell 31 (3), 424-435, 2017 | 184 | 2017 |
| Systematic reduction of cohesin differentially affects chromosome segregation, condensation, and DNA repair JM Heidinger-Pauli, O Mert, C Davenport, V Guacci, D Koshland Current biology 20 (10), 957-963, 2010 | 182 | 2010 |
| H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence A Chicas, A Kapoor, X Wang, O Aksoy, AG Evertts, MQ Zhang, BA Garcia, ... Proceedings of the National Academy of Sciences 109 (23), 8971-8976, 2012 | 159 | 2012 |
| The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence O Aksoy, A Chicas, T Zeng, Z Zhao, M McCurrach, X Wang, SW Lowe Genes & development 26 (14), 1546-1557, 2012 | 132 | 2012 |
| Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma C Lee, VA Rudneva, S Erkek, M Zapatka, LQ Chau, ... Nature communications 10 (1), 332, 2019 | 69 | 2019 |
| N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma D Kuzuoglu-Ozturk, O Aksoy, C Schmidt, R Lea, JD Larson, RRL Phelps, ... Cancer research 83 (1), 130-140, 2023 | 7 | 2023 |
| Transforming Big Data into cancer-relevant insight: an initial, multi-tier approach to assess reproducibility and relevance Cancer Target Discovery and Development Network Molecular Cancer Research 14 (8), 675-682, 2016 | 6 | 2016 |
| DDIS-33. SELECTIVE AND COMPLETE INHIBITION OF mTORC1 BY BI-STERIC mTOR INHIBITORS DRIVES THERAPEUTIC RESPONSE IN GLIOBLASTOMA Q Wen Fan, E Lorenzana, X Luo, R Lea, O Aksoy, Z An, T Ozawa, ... Neuro-Oncology 21 (Supplement_6), vi70-vi70, 2019 | | 2019 |
| CSIG-42. UNDERSTANDING THE ROLE OF TRANSLATIONAL CONTROL IN MYCN-DRIVEN MEDULLOBLASTOMA O Aksoy, Q Fan, K Shokat, D Ruggero, W Weiss Neuro-Oncology 19 (Suppl 6), vi58, 2017 | | 2017 |
| Abstract IA27: A kinase inhibitor targeted to mTORC1 drives regression in glioblastoma QW Fan, O Aksoy, R Wong, S Ilkhanizadeh, C Novotny, W Gustafson, ... Cancer Research 77 (6_Supplement), IA27-IA27, 2017 | | 2017 |
| Transforming Big Data into Cancer-Relevant Insight: An Initial, Multi-Tier Approach to Assess Reproducibility and Relevance The Cancer Target Discovery and Development Network PA Clemons, S Powers, K Smith, M Aburi, A Lavarone, A Lasorella, ... Molecular Cancer Research 14 (8), 675-682, 2016 | | 2016 |
| Selected publications SW Lee Biomacromolecules 12 (4), 987-996, 2011 | | 2011 |
| In vitro accuracy and reproducibility of two different manual probes. E Buduneli, O Aksoy, T Kose, G Atilla Int Amer Assoc Dental Researchi ADR/AADR, 2003 | | 2003 |
